showed a trendp = 0.049
36.2%, p = 0.017) and again showed a trend towards a higher prevalence of N2 lymph node metastases (41.3% vs. 23.4%, p = 0.049).
36.2%, p = 0.017) and again showed a trend towards a higher prevalence of N2 lymph node metastases (41.3% vs. 23.4%, p = 0.049).